278 related articles for article (PubMed ID: 30233794)
1. Evaluation of inflammation-based markers for predicting the prognosis of unresectable pancreatic ductal adenocarcinoma treated with chemotherapy.
Asama H; Suzuki R; Takagi T; Sugimoto M; Konno N; Watanabe K; Nakamura J; Kikuchi H; Takasumi M; Sato Y; Irie H; Hikichi T; Ohira H
Mol Clin Oncol; 2018 Oct; 9(4):408-414. PubMed ID: 30233794
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.
Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Lee MA
Asia Pac J Clin Oncol; 2018 Jun; 14(3):239-246. PubMed ID: 29044941
[TBL] [Abstract][Full Text] [Related]
3. Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer.
Takamizawa Y; Shida D; Boku N; Nakamura Y; Ahiko Y; Yoshida T; Tanabe T; Takashima A; Kanemitsu Y
BMC Cancer; 2020 Nov; 20(1):1092. PubMed ID: 33176752
[TBL] [Abstract][Full Text] [Related]
4. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.
Wang DS; Luo HY; Qiu MZ; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH
Med Oncol; 2012 Dec; 29(5):3092-100. PubMed ID: 22476808
[TBL] [Abstract][Full Text] [Related]
6. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
7. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.
Minami S; Ihara S; Kim SH; Yamamoto S; Komuta K
World J Oncol; 2018 Feb; 9(1):13-20. PubMed ID: 29581811
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of postdiagnostic inflammation-based scores in short-term overall survival of advanced pancreatic ductal adenocarcinoma patients.
Xiao Y; Xie Z; Shao Z; Chen W; Xie H; Qin G; Zhao N
Medicine (Baltimore); 2017 Dec; 96(50):e9247. PubMed ID: 29390358
[TBL] [Abstract][Full Text] [Related]
11. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of Inflammation-Based Prognostic Scores in Patients with Surgically Treated Pancreatic Ductal Adenocarcinoma.
Hong S; Hwang DW; Lee JH; Song KB; Lee W; Kwak BJ; Park Y; Kim SC
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945079
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.
Cho H; Yoo C; Kim KP; Jeong JH; Kang J; Chang HM; Lee SS; Park DH; Song TJ; Lee SK; Kim MH; Lee HC; Lim YS; Kim KM; Shim JH; Hwang S; Song GW; Moon DB; Lee JH; Lee YJ; Ryoo BY
Invest New Drugs; 2018 Jun; 36(3):496-502. PubMed ID: 29192354
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review.
Ahmad J; Grimes N; Farid S; Morris-Stiff G
Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):474-81. PubMed ID: 25308357
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy.
Shin K; Jung EK; Park SJ; Jeong S; Kim IH; Lee MA
World J Gastrointest Oncol; 2021 Aug; 13(8):915-928. PubMed ID: 34457195
[TBL] [Abstract][Full Text] [Related]
16. The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal adenocarcinoma.
Terasaki F; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
Updates Surg; 2021 Feb; 73(1):251-259. PubMed ID: 32410163
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer.
Minami S; Ogata Y; Ihara S; Yamamoto S; Komuta K
Lung Cancer (Auckl); 2017; 8():249-257. PubMed ID: 29263709
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Preoperative Nutritional and Immunological Factors in Patients with Pancreatic Ductal Adenocarcinoma.
Abe T; Nakata K; Kibe S; Mori Y; Miyasaka Y; Ohuchida K; Ohtsuka T; Oda Y; Nakamura M
Ann Surg Oncol; 2018 Dec; 25(13):3996-4003. PubMed ID: 30225838
[TBL] [Abstract][Full Text] [Related]
19. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.
Tokunaga R; Sakamoto Y; Nakagawa S; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H
Int J Clin Oncol; 2017 Aug; 22(4):740-748. PubMed ID: 28213742
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pre-treatment peripheral blood markers in pancreatic ductal adenocarcinoma and their association with S100A4 expression in tumor tissue.
Li H; Tian X; Xu Y; Pan Y; Huang Y; Zhou D; Song Z
Oncol Lett; 2019 Nov; 18(5):4523-4534. PubMed ID: 31611961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
